Td Waterhouse Canada Inc. Horizon Therapeutics Public LTD CO Transaction History

Td Waterhouse Canada Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $146,490 - $171,295	-1,480 Reduced 28.62%	3,691 $428 Million
Q2 2023 Nov 13, 2023	SELL	$96.34 - $112.38 $11,753 - $13,710	-122 Reduced 2.3%	5,171 $532 Million
Q1 2023 Nov 13, 2023	SELL	$107.32 - $113.5 $16,419 - $17,365	-153 Reduced 2.81%	5,293 $576 Million
Q4 2022 Nov 13, 2023	SELL	$62.39 - $113.8 $1,310 - $2,389	-21 Reduced 0.38%	5,446 $618 Million
Q3 2022 Nov 13, 2023	SELL	$58.92 - $84.67 $395,706 - $568,643	-6,716 Reduced 55.13%	5,467 $351 Million

Q2 2022 Nov 13, 2023	BUY	$79.4 - $116.36 $878,005 - $1.29 Million	11,058 Added 982.93%	12,183 $985 Million
Q1 2022 Nov 13, 2023	BUY	$86.42 - $109.81 $51,852 - $65,886	600 Added 114.29%	1,125 $121 Million
Q4 2021 Nov 13, 2023	BUY	$98.56 - $119.91 $51,744 - $62,952	525 New	525 $55.8 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.